These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12089586)

  • 1. Partnering challenges for startups.
    French JM
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE40-2. PubMed ID: 12089586
    [No Abstract]   [Full Text] [Related]  

  • 2. Writing your business plan.
    Cohen L
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE33-5. PubMed ID: 12089584
    [No Abstract]   [Full Text] [Related]  

  • 3. Getting reimbursement for your product in the United States.
    Gold M
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE42-4. PubMed ID: 12874979
    [No Abstract]   [Full Text] [Related]  

  • 4. Reinventing the biotech manager.
    Li J; Halal WE
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE61-3. PubMed ID: 12089592
    [No Abstract]   [Full Text] [Related]  

  • 5. Syndication--value in numbers.
    Sanborn KT
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE54-6. PubMed ID: 12089590
    [No Abstract]   [Full Text] [Related]  

  • 6. The nuts and bolts of startups.
    Kiplinger J; Last K
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE29-31. PubMed ID: 12089583
    [No Abstract]   [Full Text] [Related]  

  • 7. Leadership management needs in evolving biotech companies.
    Föller A
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE64-6. PubMed ID: 12089593
    [No Abstract]   [Full Text] [Related]  

  • 8. Filters for preparing to meet a venture capitalist.
    Christoffersen R
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981
    [No Abstract]   [Full Text] [Related]  

  • 9. Timing and the transitory nature of biotech startups.
    Bottles K
    Physician Exec; 2001; 27(4):55-7. PubMed ID: 11481895
    [No Abstract]   [Full Text] [Related]  

  • 10. Convincing a venture capitalist to invest in your idea.
    Dooley JF; Dooley JF
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980
    [No Abstract]   [Full Text] [Related]  

  • 11. Too little, too late: when is the right time for new leadership in biotech?
    Branthwaite P; Williams SJ
    Nat Biotechnol; 2004 Apr; 22(4):487-8. PubMed ID: 15034591
    [No Abstract]   [Full Text] [Related]  

  • 12. Five "C's" of successful startups.
    Blair JC
    Nat Biotechnol; 1998 May; 16 Suppl():11-2. PubMed ID: 9591252
    [No Abstract]   [Full Text] [Related]  

  • 13. Value drivers in licensing deals.
    Arnold K; Coia A; Saywell S; Smith T; Minick S; Löffler A
    Nat Biotechnol; 2002 Nov; 20(11):1085-9. PubMed ID: 12410249
    [No Abstract]   [Full Text] [Related]  

  • 14. Proactive accounting: a key factor in the success of biotechnology startups.
    Jester C
    Nat Biotechnol; 2004 Jan; 22(1):127-9. PubMed ID: 14725301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beating back the bushes.
    Nat Biotechnol; 2002 Sep; 20(9):855. PubMed ID: 12205488
    [No Abstract]   [Full Text] [Related]  

  • 16. Assets for mastering media relations.
    Steinerman P
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE59-61. PubMed ID: 12874984
    [No Abstract]   [Full Text] [Related]  

  • 17. Let's make a deal.
    Anderson HJ
    Health Data Manag; 2008 Feb; 16(2):84, 86, 88. PubMed ID: 18354959
    [No Abstract]   [Full Text] [Related]  

  • 18. Protecting innovation in biotechnology startups.
    Steffe EK; Shea TJ
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE51-3. PubMed ID: 12874982
    [No Abstract]   [Full Text] [Related]  

  • 19. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 20. Developing market.
    Taylor W
    Nat Biotechnol; 2004 Sep; 22(9):1075. PubMed ID: 15340463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.